飛天誠信(300386.SZ):子公司收到政府補助
格隆匯5月30日丨飛天誠信(300386.SZ)公佈,近日,公司的控股子公司宏思電子收到有關區塊鏈邊緣計算硬件加速技術課題的專項經費合計1,150,000.00元,該項目由中國科學技術部發起並撥付款項。該專項經費撥付款系由宏思電子參與相關課題研究而產生,與企業日常經營活動無關,相應補助款不具備可持續性。該筆政府補助系第一筆撥付款,以現金形式補助,未來該課題專項經費根據研究進度進行撥付,總計3,000,000.00元,此外公司還累計收到軟件產品增值税即徵即退款3,363,667.44元,該項補助款具備可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.